-
公开(公告)号：EP2341902A1
公开(公告)日：2011-07-13
申请号：EP09783132.5
申请日：2009-09-17
申请人： Novartis AG
IPC分类号： A61K31/351 , C07D309/10 , A61P3/10
CPC分类号： C07D309/10 , C07D405/06
摘要： The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts, to formulations and uses in the treatment of metabolic disorders.
-
公开(公告)号：EP2491050A2
公开(公告)日：2012-08-29
申请号：EP10765811.4
申请日：2010-10-20
申请人： Novartis AG
发明人： BEBERNITZ, Gregory Raymond , BOCK, Mark G. , BHUNIYA, Debnath , DATRANGE, Laxmikant , KURHADE, Suresh Eknath , PALLE, P. Venkata , REDDY,Dumbala Srinivas
IPC分类号： C07H15/203 , C07H15/26 , C07H17/00 , C07H19/04 , C07D309/10 , C07D309/30 , C07D405/10 , C07D407/10 , C07D407/12 , C07D409/04 , C07D409/10 , C07D409/12 , C07D413/10 , C07D493/10 , C07D498/04 , C07D491/107 , A61K31/7042 , A61K31/7034 , A61K31/7056 , A61K31/351 , A61P3/10
CPC分类号： C07H17/00 , A61K31/351 , A61K31/7034 , A61K31/7042 , A61K31/7056 , A61K38/28 , A61K45/06 , C07D309/10 , C07D309/30 , C07D405/10 , C07D407/10 , C07D407/12 , C07D409/04 , C07D409/10 , C07D409/12 , C07D413/10 , C07D491/107 , C07D493/10 , C07D498/04 , C07H15/203 , C07H15/26 , C07H19/04 , A61K2300/00
摘要： This invention relates to compounds represented by formula (I) wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.
摘要翻译： 本发明涉及由式（I）表示的化合物：其中变量如上文所定义，其可用于治疗D-葡萄糖共转运蛋白（SGLT）介导的疾病和病症，例如， 糖尿病。 本发明还提供了治疗这些疾病和病症以及组合物等的治疗方法。
-
公开(公告)号：EP2342187A1
公开(公告)日：2011-07-13
申请号：EP09783121.8
申请日：2009-09-17
申请人： Novartis AG
IPC分类号： C07D309/10 , A61K31/351 , A61P3/10
CPC分类号： C07D309/10
摘要： The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts, to formulations and uses in the treatment of, interalia, metabolic disorders.
-
公开(公告)号：EP2491029A1
公开(公告)日：2012-08-29
申请号：EP10768927.5
申请日：2010-10-19
申请人： Novartis AG
发明人： BEBERNITZ, Gregory, Raymond , BOCK, Mark, G. , REDDY, Dumbala Srinivas , HAJARE, Atul Kashinath , VYAVAHARE, Vinod , BHOSALE, Sandeep Bhausaheb , KURHADE, Suresh Eknath , SALUNKHE, Videsh , SHAIKH, Nadim, S. , BHUNIYA, Debnath , PALLE, P., Venkata , FENG, Lili , LIANG, Jessica
IPC分类号： C07D405/10 , C07D407/10 , C07D413/10 , A61K31/70 , A61P3/10
CPC分类号： A61K31/7052 , A61K31/7048 , A61K31/706 , C07D405/10 , C07D407/10 , C07D413/10 , C07H7/04
摘要： This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.
-
公开(公告)号：EP2491029B1
公开(公告)日：2016-02-10
申请号：EP10768927.5
申请日：2010-10-19
申请人： Novartis AG
发明人： BEBERNITZ, Gregory, Raymond , BOCK, Mark, G. , REDDY, Dumbala Srinivas , HAJARE, Atul Kashinath , VYAVAHARE, Vinod , BHOSALE, Sandeep Bhausaheb , KURHADE, Suresh Eknath , SALUNKHE, Videsh , SHAIKH, Nadim, S. , BHUNIYA, Debnath , PALLE, P., Venkata , FENG, Lili , LIANG, Jessica
IPC分类号： C07D405/10 , C07D407/10 , C07D413/10 , A61K31/70 , A61P3/10
CPC分类号： A61K31/7052 , A61K31/7048 , A61K31/706 , C07D405/10 , C07D407/10 , C07D413/10 , C07H7/04
摘要： This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.
摘要翻译： 本发明涉及由式（I）表示的化合物：其中变量如上文所定义，其可用于治疗D-葡萄糖共转运蛋白（SGLT）介导的疾病和病症，例如， 糖尿病。 本发明还提供了治疗这些疾病和病症以及组合物等的治疗方法。
-
-
-
-
搜索结果
5 条记录 (耗时 0.016 秒)
